Aquestive Therapeutics, Inc.

Historical 13F Holders

Symbol
AQST
CUSIP
03843E104
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 03843E104 since 12/18/2024, largest first.

Filer % of Class Filed
Bass Edward P 13G
7.5% 10/7/2026
Event 10/7/2026
BlackRock, Inc. 13G/A 6.4% 7/27/2026
Event 6/30/2026
RTW Investments, LP 13G
5.2% 11/14/2025
Event 9/30/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (2)
Venrock Healthcare Capital Partners III, L.P. 13G/A
2.9% 2/14/2025
Event 12/31/2024
Bratton Douglas K 13G/A
0.6% 10/7/2026
Event 10/7/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 68 17.6 M $81.6M
2026 Q2 186 72.0 M $301M
2026 Q1 180 71.9 M $299M
2025 Q4 185 72.3 M $467M
2025 Q3 154 66.5 M $372M
2025 Q2 118 48.0 M $159M
2025 Q1 122 44.3 M $131M
2024 Q4 116 43.4 M $154M
2024 Q3 118 46.8 M $237M
2024 Q2 99 43.1 M $112M
2024 Q1 98 41.8 M $178M
2023 Q4 58 23.9 M $48.3M
2023 Q3 49 22.9 M $21.5M
2023 Q2 55 19.1 M $31.5M
2023 Q1 37 14.9 M $17.0M
2022 Q4 38 15.0 M $13.6M
2022 Q3 47 15.9 M $18.7M
2022 Q2 47 16.7 M $10.8M
2022 Q1 53 15.5 M $40.7M
2021 Q4 54 16.4 M $63.6M
2021 Q3 48 14.8 M $64.4M
2021 Q2 62 15.6 M $62.0M
2021 Q1 66 16.6 M $86.4M
2020 Q4 66 19.2 M $103M
2020 Q3 63 19.9 M $96.5M
2020 Q2 60 18.5 M $90.0M
2020 Q1 43 16.0 M $35.0M
2019 Q4 57 17.5 M $102M
2019 Q3 36 13.6 M $43.2M
2019 Q2 41 14.5 M $61.0M
2019 Q1 50 14.4 M $99.6M
2018 Q4 37 14.4 M $90.8M
2018 Q3 45 16.1 M $282M